Retatrutide is a newly developed therapy that acts as a potent GLP-1 receptor agonist. This breakthrough approach holds significant promise for managing type 2 diabetes. By mimicking the actions of natural GLP-1, Retatrutide improves insulin secretion and limits glucagon release, leading to improved glycemic control. Clinical trials have demonstrat